Stay updated on Brexanolone in COVID-19 ARDS Clinical Trial
Sign up to get notified when there's something new on the Brexanolone in COVID-19 ARDS Clinical Trial page.

Latest updates to the Brexanolone in COVID-19 ARDS Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoChange DetectedRevision note added: v3.3.2. Revision note removed: v3.2.0. No visible changes to study details, eligibility criteria, or page layout.SummaryDifference0.1%

- Check19 days agoChange DetectedThe page no longer displays the government funding operating status notice. It previously directed users to cc.nih.gov and opm.gov for updates.SummaryDifference0.4%

- Check33 days agoChange DetectedNew screenshot shows a reorganized layout and updated styling of the page header and sections. Core study data such as title, eligibility criteria, locations, enrollment, and primary outcomes appear unchanged.SummaryDifference0.5%

- Check62 days agoChange DetectedUpdated status notice and version to v3.2.0, replacing v3.1.0; added information about government funding lapse and operating status, and where to find details.SummaryDifference5%

- Check69 days agoChange DetectedUpdated page now shows Revision: v3.1.0 and removes several drug-safety topic sections (Drug Safety, Counterfeit Drugs, Pharmaceutical Preparations, Substandard Drugs).SummaryDifference0.6%

- Check84 days agoChange DetectedRevision updated to v3.0.2 (replacing v3.0.1). The Back to Top UI element has been removed.SummaryDifference0.3%

Stay in the know with updates to Brexanolone in COVID-19 ARDS Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Brexanolone in COVID-19 ARDS Clinical Trial page.